Investigating the comparability of wearable accelerometer methods in the association between physical activity and cardiovascular disease: a cohort study using UK Biobank

Read full text
Authors: Yacine Lapointe, Aayush Kapur, Abhinav Sharma, Janna Panter, Daniel Fuller, Hiroshi Mamiya
Cited by: 1
References: 22

Abstract

OBJECTIVE: The selection of accelerometer processing methods may influence the shape of the dose-response association between wearable-measured physical activity and health outcomes. We aimed to compare the association of stroke and myocardial infarction with Moderate-Vigorous Physical Activity (MVPA) assessed by three accelerometer-generated metrics: Low-pass Filtered Euclidean Norm Minus One (LFENMO), machine-learning, and activity counts. METHODS: We computed MVPA durations in the UK Biobank accelerometer sub-cohort recruited between 2013 and 2015 in the UK. The outcomes, incident stroke and myocardial infarction, were followed up until December 2022. We used Cox regression and a restricted cubic spline to estimate the dose-response association for each of the three MVPA metrics. RESULTS: There were 90,237 cardiovascular disease-free participants at baseline. We observed 1298 incident strokes and 2031 myocardial infarctions. For stroke, a linear decrease in hazard ratio was observed with machine-learning, but not with LFENMO and activity counts. For myocardial infarction, machine-learning and LFENMO showed a curvilinear decrease in hazard ratios, whereas activity counts showed a linear decrease. CONCLUSIONS: The dose-response associations between MVPA and cardiovascular disease varied markedly across the three accelerometer-derived MVPA metrics. Research using a single accelerometer metric may caution about the interpretation of the association.

Fields of Study & Subjects

Physical Activity and Health Cardiovascular and exercise physiology Context-Aware Activity Recognition Systems

Publication details

Journal / source
Preventive Medicine
Publisher
Elsevier BV
Volume
209
Pages
108603–108603
Publication date
15 May 2026
Language
EN